Pre-motor signs of PD are related to SN hyperechogenicity assessed by TCS in an elderly population

Neurobiology of Aging

Volumn 32, Issue 9, 2011, Pages 1599-1606

  Liepelt, Inga ^a   Behnke, Stefanie ^b   Schweitzer, Katharine ^a   Wolf, Björn ^a   Godau, Jana ^a   Wollenweber, Frank ^b   Dillmann, Ulrich ^b   Gaenslen, Alexandra ^a   Di Santo, Adriana ^a   Maetzler, Walter ^a   Berg, Daniela ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

Author keywords

Parkinson's disease; Pre motor phase; Transcranial ultrasound

Indexed keywords

ADULT; AGED; ARM MOVEMENT; ARTICLE; COHORT ANALYSIS; CONSTIPATION; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE MARKER; DOPPLER ECHOGRAPHY; FAMILY HISTORY; FEMALE; GERMANY; HIGH RISK POPULATION; HUMAN; HYPOSMIA; MAJOR CLINICAL STUDY; MALE; MOTOR DYSFUNCTION; NERVOUS SYSTEM PARAMETERS; PARKINSON DISEASE; PARKINSONISM; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SEX DIFFERENCE; SUBSTANTIA NIGRA HYPERECHOGENICITY; UNIFIED PARKINSON DISEASE RATING SCALE;

AGED; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; PROSPECTIVE STUDIES; RISK FACTORS; SUBSTANTIA NIGRA; ULTRASONOGRAPHY, DOPPLER, TRANSCRANIAL;

EID: 79960120604     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2009.10.004     Document Type: Article

References (44)

1. Baba Y., Putzke J.D., Whaley N.R., Wszolek Z.K., Uitti R.J. Gender and the Parkinson's disease phenotype. J. Neurol. 2005, 252:1201-1205.
2. Behnke S., Double K.L., Duma S., Broe G.A., Guenther V., Becker G., Halliday G.M. Substantia nigra echomorphology in the healthy very old: correlation with motor slowing. Neuroimage 2007, 34:1054-1059.
3. Berg D. Marker for a preclinical diagnosis of Parkinson's disease as a basis for neuroprotection. J. Neural Transm. [Suppl.] 2006, 71:1-10.
4. Berg D. Biomarkers for the early detection of Parkinson's and Alzheimer's disease. Neurodegener. Dis. 2008, 5:133-136.
5. Berg D., Becker G., Zeiler B., Tucha O., Hofmann E., Preier M., Benz P., Jost W., Reiners K., Lange K.W. Vulnerability of the nigrostriatal system as detected by transcranial ultrasound. Neurology 1999, 53:1026-1031.
6. Berg D., Behnke S., Walter U. Application of transcranial sonography in extrapyramidal disorders: updated recommendations. Ultraschall. Med. 2006, 27:12-19.
7. Berg D., Roggendorf W., Schroder U., Klein R., Tatschner T., Benz P., Tucha O., Preier M., Lange K.W., Reiners K., Gerlach M., Becker G. Echogenicity of the substantia nigra: association with increased iron content and marker for susceptibility to nigrostriatal injury. Arch. Neurol. 2002, 59:999-1005.
8. Berg D., Siefker C., Becker G. Echogenicity of the substantia nigra in Parkinson's disease and its relation to clinical findings. J. Neurol. 2001, 248:684-689.
9. Berg D., Siefker C., Ruprecht-Dorfler P., Becker G. Relationship of substantia nigra echogenicity and motor function in elderly subjects. Neurology 2001, 56:13-17.
10. Brooks D.J. The early diagnosis of Parkinson's disease. Ann. Neurol. 1998, 44:S10-S18.
11. Burns J.M., Galvin J.E., Roe C.M., Morris J.C., McKeel D.W. The pathology of the substantia nigra in Alzheimer disease with extrapyramidal signs. Neurology 2005, 64:1397-1403.
12. Copeland J.R., Beekman A.T., Braam A.W., Dewey M.E., Delespaul P., Fuhrer R., Hooijer C., Lawlor B.A., Kivela S.L., Lobo A., Magnusson H., Mann A.H., Meller I., Prince M.J., Reischies F., Roelands M., Skoog I., Turrina C., deVries M.W., Wilson K.C. Depression among older people in Europe: the EURODEP studies. World Psychiatry 2004, 3:45-49.
13. de Lau L.M., Koudstaal P.J., Hofman A., Breteler M.M. Subjective complaints precede Parkinson disease: the Rotterdam study. Arch. Neurol. 2006, 63:362-365.
14. de Rijk M.C., Launer L.J., Berger K., Breteler M.M., Dartigues J.F., Baldereschi M., Fratiglioni L., Lobo A., Martinez-Lage J., Trenkwalder C., Hofman A. Prevalence of Parkinson's disease in Europe: a collaborative study of population-based cohorts. Neurology 2000, 54:S21-S23. Neurologic Diseases in the Elderly Research Group.
15. Doty R.L., Shaman P., Kimmelman C.P., Dann M.S. University of Pennsylvania smell identification test: a rapid quantitative olfactory function test for the clinic. Laryngoscope 1984, 94:176-178.
16. Elbaz A., Grigoletto F., Baldereschi M., Breteler M.M., Manubens-Bertran J.M., Lopez-Pousa S., Dartigues J.F., Alperovitch A., Tzourio C., Rocca W.A. Familial aggregation of Parkinson's disease: a population-based case-control study in Europe. Neurology 1999, 52:1876-1882. EUROPARKINSON Study Group.
17. Fearnley J.M., Lees A.J. Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain 1991, 114:2283-2301.
18. Hawkes C. Olfaction in neurodegenerative disorder. Mov. Disord. 2003, 18:364-372.
19. Hilker R., Schweitzer K., Coburger S., Ghaemi M., Weisenbach S., Jacobs A.H., Rudolf J., Herholz K., Heiss W.D. Nonlinear progression of Parkinson disease as determined by serial positron emission tomographic imaging of striatal fluorodopa F 18 activity. Arch. Neurol. 2005, 62:378-382.
20. Hummel T., Konnerth C.G., Rosenheim K., Kobal G. Screening of olfactory function with a four-minute odor identification test: reliability, normative data, and investigations in patients with olfactory loss. Ann. Otol. Rhinol. Laryngol. 2001, 110:976-981.
21. Khan N.L., Brooks D.J., Pavese N., Sweeney M.G., Wood N.W., Lees A.J., Piccini P. Progression of nigrostriatal dysfunction in a parkin kindred: an [18F]dopa PET and clinical study. Brain 2002, 125:2248-2256.
22. Korczyn A.D. Autonomic nervous system disturbances in Parkinson's disease. Adv. Neurol. 1990, 53:463-468.
23. Kurz M., Alves G., Aarsland D., Larsen J.P. Familial Parkinson's disease: a community-based study. Eur. J. Neurol. 2003, 10:159-163.
24. Lees A.J. When did Ray Kennedy's Parkinson's disease begin?. Mov. Disord. 1992, 7:110-116.
25. Liepelt I., Wendt A., Schweitzer K.J., Wolf B., Godau J., Gaenslen A., Bruessel T., Berg D. Substantia nigra hyperechogenicity assessed by transcranial sonography is related to neuropsychological impairment in the elderly population. J. Neural Transm. 2008, 115:993-999.
26. Louis E.D., Bennett D.A. Mild Parkinsonian signs: an overview of an emerging concept. Mov. Disord. 2007, 22:1681-1688.
27. Louis E.D., Tang M.X., Mayeux R. Factor structure of parkinsonian signs in the community-dwelling elderly. Mov. Disord. 2004, 19:268-272.
28. Marder K., Tang M.X., Mejia H., Alfaro B., Cote L., Louis E., Groves J., Mayeux R. Risk of Parkinson's disease among first-degree relatives: a community-based study. Neurology 1996, 47:155-160.
29. Mizuno Y., Hattori N., Kubo S., Sato S., Nishioka K., Hatano T., Tomiyama H., Funayama M., Machida Y., Mochizuki H. Progress in the pathogenesis and genetics of Parkinson's disease. Philos. Trans. R. Soc. Lond B Biol. Sci. 2008, 363:2215-2227.
30. Peppas G., Alexiou V.G., Mourtzoukou E., Falagas M.E. Epidemiology of constipation in Europe and Oceania: a systematic review. BMC Gastroenterol. 2008, 8:5.
31. Poewe W. Dysautonomia and cognitive dysfunction in Parkinson's disease. Mov. Disord. 2007, 22(Suppl. 17):S374-S378.
32. Ponsen M.M., Stoffers D., Booij J., Eck-Smit B.L., Wolters E.C., Berendse H.W. Idiopathic hyposmia as a preclinical sign of Parkinson's disease. Ann. Neurol. 2004, 56:173-181.
33. Ross G.W., Petrovitch H., Abbott R.D., Tanner C.M., Popper J., Masaki K., Launer L., White L.R. Association of olfactory dysfunction with risk for future Parkinson's disease. Ann. Neurol. 2008, 63:167-173.
34. Ruprecht-Dorfler P., Berg D., Tucha O., Benz P., Meier-Meitinger M., Alders G.L., Lange K.W., Becker G. Echogenicity of the substantia nigra in relatives of patients with sporadic Parkinson's disease. Neuroimage 2003, 18:416-422.
35. Ruprecht-Dorfler P., Klotz P., Becker G., Berg D. Substantia nigra hyperechogenicity correlates with subtle motor dysfunction in tap dancers. Parkinsonism Relat. Disord. 2007, 13:362-364.
36. Schweitzer K.J., Behnke S., Liepelt I., Wolf B., Grosser C., Godau J., Gaenslen A., Bruessel T., Wendt A., Abel F., Muller A., Gasser T., Berg D. Cross-sectional study discloses a positive family history for Parkinson's disease and male gender as epidemiological risk factors for substantia nigra hyperechogenicity. J. Neural Transm. 2007, 114:1167-1171.
37. Siderowf A., Jennings D., Connolly J., Doty R.L., Marek K., Stern M.B. Risk factors for Parkinson's disease and impaired olfaction in relatives of patients with Parkinson's disease. Mov. Disord. 2007, 22:2249-2255.
38. Sommer U., Hummel T., Cormann K., Mueller A., Frasnelli J., Kropp J., Reichmann H. Detection of presymptomatic Parkinson's disease: combining smell tests, transcranial sonography, and SPECT. Mov. Disord. 2004, 19:1196-1202.
39. Tolosa E., Compta Y., Gaig C. The premotor phase of Parkinson's disease. Parkinsonism Relat. Disord. 2007, 13(Suppl.):S2-S7.
40. Vingerhoets F.J., Snow B.J., Lee C.S., Schulzer M., Mak E., Calne D.B. Longitudinal fluorodopa positron emission tomographic studies of the evolution of idiopathic parkinsonism. Ann. Neurol. 1994, 36:759-764.
41. Walter U., Behnke S., Eyding J., Niehaus L., Postert T., Seidel G., Berg D. Transcranial brain parenchyma sonography in movement disorders: state of the art. Ultrasound Med. Biol. 2007, 33:15-25.
42. Walter U., Hoeppner J., Prudente-Morrissey L., Horowski S., Herpertz S.C., Benecke R. Parkinson's disease-like midbrain sonography abnormalities are frequent in depressive disorders. Brain 2007, 130:1799-1807.
43. Walter U., Prudente-Morrissey L., Herpertz S.C., Benecke R., Hoeppner J. Relationship of brainstem raphe echogenicity and clinical findings in depressive states. Psychiatry Res. 2007, 155:67-73.
44. Wolters E.C., Braak H. Parkinson's disease: premotor clinico-pathological correlations. J. Neural Transm. Suppl. 2006, 309-319.